Reprint
Pharmaceutical Residues in the Environment
Edited by
November 2020
292 pages
- ISBN978-3-03943-485-5 (Hardback)
- ISBN978-3-03943-486-2 (PDF)
This book is a reprint of the Special Issue Pharmaceutical Residues in the Environment that was published in
Chemistry & Materials Science
Medicine & Pharmacology
Summary
Pharmaceuticals, due to their pseudo-persistence and biological activity as well as their extensive use in human and veterinary medicine, are a class of environmental contaminants that is of emerging concern. In contrast to some conventional pollutants, they are continuously delivered at low levels, which might give rise to toxicity even without high persistence rates. These chemicals are designed to have a specific physiological mode of action and to resist frequently inactivation before exerting their intended therapeutic effect. These features, among others, result in the bioaccumulation of pharmaceuticals which are responsible for toxic effects in aquatic and terrestrial ecosystems. It is extremely important to know how to remove them from the environment and/or how to implement procedures or treatments resulting in their biological inactivation. Although great advances have been made in their detection in aquatic matrices, there remains limited analytical methodologies available for the trace analysis of target and non-target pharmaceuticals in matrices such as soils, sediments, or biota. There are still many gaps in the data on their fate and behavior in the environment as well as on their threats to ecological and human health. This book has included nine current research and three review articles in this field.
Format
- Hardback
License
© 2021 by the authors; CC BY license
Keywords
ifosfamide; cyclophosphamide; 5-fluorouracil; cytostatic drug; BDD anode; electrochemical oxidation; intermediates; lincomycin; monensin; roxarsone; migration; residual; toxicity; pharmaceuticals; endocrine disrupting compounds; hydroponic cultivation; determining target pollutants in plant materials; municipal wastewater treatment plants; ionic liquids; green chemistry; environmental and biological samples; sample preparation; determination of pharmaceuticals; chromatographic methods; electromigration techniques; sulfamethoxazole; antibiotic resistance genes; sul genes; bacterial community; constructed wetlands; environmental contaminants; pharmaceuticals occurrence; pharmaceuticals; aquatic compartments; pharmaceuticals; soil; poultry farms; ultra-high performance liquid chromatography; antibiotics, antibiotic resistance; antibiotics; wastewater; sewage sludge; risk assessment; removal efficiency; LC-MS/MS analysis; Spirotox; fluoxetine; sertraline; paroxetine; mianserin; pharmaceuticals in the environment; wastewaters; pharmaceutical residues; constructed wetlands; conventional wastewater treatments; solid phase extraction; ultra-high performance liquid chromatography; environmental contaminants; pharmaceuticals; pharmaceuticals toxicity; environmental risk assessment; aquatic compartments; antibiotic resistance genes (ARGs); antibiotic-resistant bacteria (ARB); wastewater treatment plants (WWTPs); activated sludge (AS); constructed wetlands (CWs); environmental pollution; spread of resistance; tetracyclines; sulfonamides; pharmaceutical residues; fate in the environment; fate in WWTPs; ecotoxicity; antibiotic resistance; development of methods; environmental risk assessment